OUR PERFORMANCE - Syngenta...Long Term 2001-2015. BROAD CROP AND GEOGRAPHICAL FOOTPRINT . 9 . Sales in 90+ countries . Total: US$12.8bn . 8 key crops . North America . 3.4bn-4% CER

OUR PERFORMANCE DECEMBER 2015

OUTLINE

2

Commercial Performance

Profitability Cash and capital management

Investments Shareholder return

Sales evolution

Market share development

Operational footprint

Operating expenses

EBITDA evolution

Free cash flow conversion

Receivables in emerging markets

Working capital to sales ratio

R&D investments

Capital investments

Earnings per share

Dividend progression

KEY FACTS

3

Long term 2001–2015

Short term 2010–2015


Profitability

Cash and capital management

Investments

Shareholder return*

Sales:

Expenses/ Sales

Free cash flow conversion:

R&D spend CAGR:

Dividend CAGR*:

Sales:

Dividend CAGR**:

CAGR CAGR +6% +3%

850bp 200bp

40%

+5% +5%

+28% +11%

Expenses/ Sales

Free cash flow conversion:

36% R&D spend CAGR:

improvement improvement

* Dividends paid in 2015 for financial year 2014

LONG TERM

4

2001 – 2015

All figures as reported unless otherwise stated

Long Term 2001-2015

0

2

4

6

8

10

12

14

16

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Crop Protection (including Professional Products) Seeds (including Flowers)

SALES EVOLUTION

5

$bn

Group sales CAGR: +6%

Seeds sales CAGR: +9%

CP sales CAGR: +5%


Source: Company estimates

Long Term 2001-2015

0

10

20

30

40

50

60

17.0%

18.0%

19.0%

20.0%

21.0%

22.0%

23.0%

2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Crop Protection & Seed Care market Syngenta Crop Protection & Seed Care market share

CROP PROTECTION MARKET SHARE

6


Source: Phillips McDougall. Excludes professional products, includes intercompany sales

Market share %

Market value in $bn

Expansion in emerging markets

Financial crisis, credit constraint in

emerging markets

Technology transition to

SDHI fungicides

Long Term 2001-2015

0

10

20

30

40

50

60

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

18.0%

20.0%

2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Seeds market Syngenta Seeds market share

SEEDS MARKET SHARE

7

Market share %

Market value in $bn


Vegetables & Flowers acquisitions

Trait offer expansion

Licensing agreement

with DuPont

Source: Phillips McDougall Excludes: Flower seeds, public seeds and minor crops (e.g. forage, grasses, turf, alfalfa, sorghum)

Long Term 2001-2015 8

MARKET SHARE SUMMARY

Source: Phillips McDougall. Crop Protection data excludes professional products, includes intercompany sales Seeds data excludes flower seeds, public seeds and minor crops (forage, grasses, turf, alfalfa, sorghum)

#1 in CP #3 in Seeds 2014 sales: $11.4bn

2014 sales: $3.2bn

Syngenta 20% Bayer 18% BASF 13% Dow 10% Monsanto 9% DuPont 7% Other 23%


Syngenta 8%

Monsanto 26%

DuPont 20%

Dow 4% Bayer 3% Other 39%

Long Term 2001-2015

BROAD CROP AND GEOGRAPHICAL FOOTPRINT

9

Sales in 90+ countries Total: US$12.8bn

8 key crops

North America

3.4bn -4% CER

EAME

3.9bn +10% CER

LATAM

3.6bn -5% CER

APAC

1.8bn -3% CER

52% sales from

emerging markets in 2015

Specialty crops $1.9bn

Rice $0.6bn

Diverse field crops

$1.1bn

Cereals $1.7bn

Corn $3.2bn

Sugar cane $0.3bn

Soybean $2.5bn

Vegetables $1.5bn

Lawn & Garden $0.6bn


Source: Syngenta estimates

2015 integrated sales by region

Source: Company results

Long Term 2001-2015

4

6

8

10

12

14

16

20

25

30

35

40

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

OPERATING COST MANAGEMENT

10

% of sales Sales

$bn

Expenses as reported

Profitability


Long Term 2001-2015

0

2

4

6

8

10

12

14

16

18

15

17

19

21

23

25

27

29

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Sales Reported EBITDA % of Sales CER EBITDA % of Sales

11

Profitability

% of sales

Sales $bn

EBITDA at CER

EBITDA as reported


Trait licensing

agreement with

DuPont

2012 trait

licensing, seed

production costs

EBITDA PERFORMANCE VS. CURRENCY IMPACT

Trait licensing

agreement with

KWS and Limagrain

Long Term 2001-2015

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

-

200

400

600

800

1'000

1'200

1'400

1'600

1'800

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Free Cash Flow before acquisitions EBITDA conversion

FREE CASH FLOW CONVERSION

12

Free cash flow before

acquisitions $m % of EBITDA

Period average 40% Target >40%

Cash & capital management


Long Term 2001-2015

TRADE WORKING CAPITAL DEVELOPMENT

52% 47%

41% 40% 40% 43%

39% 37% 42%

39% 37% 35% 40% 42%

46%

-30%

-20%

-10%

0%

10%

20%

30%

40%

50%

60%

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Year end trade receivables % of sales Year end trade payables % of salesYear end inventory % of sales Average trade working capital % of sales

13


% of sales


Long Term 2001-2015

10

15

20

25

30

35

40

0

1

2

3

4

5

6

7

8

9

2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Emerging market sales Total receivables % of sales

EXPANSION IN EMERGING MARKETS EVOLUTION OF WORKING CAPITAL

14

Sales in $bn

% of sales


34% 2005

52% 2015

Emerging market sales % of total group

Source: Company results, Syngenta estimates

Long Term 2001-2015

4

5

6

7

8

9

10

11

12

0

500

1'000

1'500

2'000

2'500

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Chemistry GM traits Breeding

New technologies R&D % of sales Cumulated sales/R&D

EVOLUTION OF R&D INVESTMENTS

15

Investments

Spend $m

R&D % of sales Cumulated sales/R&D

+5% CAGR

+7% +7% +2%

Globalization of R&D Post-merger Building the pipeline R&D spend


Long Term 2001-2015

-800

-700

-600

-500

-400

-300

-200

-100

00%

1%

2%

3%

4%

5%

6%

7%

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Investments in fixed tangible and intangible assets less disposals Investments as % of sales

CAPITAL INVESTMENTS

16

Investments

Source: Company results. Figures include intangible investments, net of disposals

% of sales $m

Long Term 2001-2015

DIVIDEND PAYOUT & CASH RETURN TO SHAREHOLDERS

0

2

4

6

8

10

12

14

0

5

10

15

20

25

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

EPS Dividend

17

Shareholder return

Dividend CAGR** +28% Dividend payout

EPS CAGR +16%

EPS* $

Dividend $

Cash return to shareholders

$m

* Fully diluted basis, excl. restructuring and impairment. CAGR as reported. ** 2001-2014 period Dividend paid in Swiss Francs. Numbers include dividend and par value reduction Source: Company results

0

200

400

600

800

1'000

1'200

1'400

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Dividend payout Share repurchase

SHORT TERM

18

2010 – 2015

All figures as reported unless otherwise stated

Short Term 2010-2015

SALES EVOLUTION

19

0

2

4

6

8

10

12

14

16

18

20

22

24

2010 2011 2012 2013 2014 2015

Crop Protection (including Professional Products) Seeds (including Flowers)

Group sales CAGR: +3%

Seeds sales CAGR: +2%

CP sales CAGR: +3%


$bn



11'641

15'874

13'411

2'463

2'524

1'709

2010 Sales Volume Price 2015 Sales at 2010rates

Currency 2015 Sales

SALES DEVELOPMENT

20


$m CER sales CAGR:

6%



-15.0%

-10.0%

-5.0%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3

2011 2012 2013 2014 2015

Syngenta* Top 6 companies**

CROP PROTECTION SALES GROWTH

21


Q-o-Q growth rates

Source: Company results, Syngenta estimates * Including intercompany sales and professional products ** Top 6: BASF AgSolutions, Bayer Crop Science, Dow AgSciences, DuPont, Monsanto, Syngenta

Short Term 2010-2015 22

-40.0%

-30.0%

-20.0%

-10.0%

0.0%

10.0%

20.0%

30.0%

40.0%

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3

2011 2012 2013 2014 2015

Syngenta* Top 5 companies**

SEEDS SALES GROWTH


Source: Company results, Syngenta estimates * Excluding Flowers ** Top 5: Bayer CropScience, Dow AgSciences, DuPont (Pioneer), Monsanto, Syngenta

2012 trait licensing

deal

Trait licensing

agreement with

DuPont

Q-o-Q growth rates


4

6

8

10

12

14

16

17

19

21

23

25

27

2010 2011 2012 2013 2014 2015

Sales Reported EBITDA % of Sales CER EBITDA % of Sales

EBITDA PERFORMANCE VS. CURRENCY IMPACT Profitability

23

% of sales

Sales $bn


Trait licensing

agreement with

KWS and Limagrain

Trait licensing

agreement with

DuPont

2012 trait

licensing, seed

production costs


4

6

8

10

12

14

16

25

30

35

40

2010 2011 2012 2013 2014 2015

Sales Function costs % of Sales

OPERATING COST MANAGEMENT

24

Profitability

% of sales

Sales $bn

Expenses as reported



0%

10%

20%

30%

40%

50%

60%

0

200

400

600

800

1'000

1'200

1'400

1'600

1'800

2010 2011 2012 2013 2014 2015

Free Cash Flow before acquisitions EBITDA conversion

FREE CASH FLOW CONVERSION

25


Free cash flow before

acquisitions $m % of EBITDA

Period average 36% Target >40%



39% 37% 35% 40% 42%

46%

-30%

-20%

-10%

0%

10%

20%

30%

40%

50%

60%

2010 2011 2012 2013 2014 2015

Year end trade receivables % sales Year end trade payables % salesYear end inventory % sales Average trade working capital % sales

TRADE WORKING CAPITAL DEVELOPMENT

26


In % of sales



0

1

2

3

4

5

6

7

8

9

25

30

35

40

45

50

55

2010 2011 2012 2013 2014 2015Emerging market sales Emerging market sales % of total salesTotal period end working capital % sales

EXPANSION IN EMERGING MARKETS WORKING CAPITAL DEVELOPMENT

27


% of sales

Sales $bn



EVOLUTION OF R&D INVESTMENTS

4.0

5.0

6.0

7.0

8.0

9.0

10.0

11.0

12.0

0

500

1'000

1'500

2'000

2'500

2010 2011 2012 2013 2014 2015

Chemistry GM traits BreedingNew technologies R&D % of sales Cumulated sales/R&D

28

+5% CAGR

R&D spend

R&D investment $m

2010-2015 cumulated growth =

$280m Investment in new capabilities

Sustained investment in chemistry

Registration of full GM trait portfolio

Global development platform in Seeds


R&D % of sales Cumulated sales/R&D

Investments


CAPITAL INVESTMENTS

29

-800

-700

-600

-500

-400

-300

-200

-100

00.0%

0.5%

1.0%

1.5%

2.0%

2.5%

3.0%

3.5%

4.0%

4.5%

5.0%

2010 2011 2012 2013 2014 2015

Investments in fixed tangible and intangible assets less disposals Investments as % of sales

% of sales $m

Investments

Source: Company results. Figures include intangible investments, net of disposals


DIVIDEND PAYOUT & CASH RETURN TO SHAREHOLDERS

0

200

400

600

800

1'000

1'200

1'400

2010 2011 2012 2013 2014 2015Dividend payout Share repurchase

0

2

4

6

8

10

12

14

16

18

0

5

10

15

20

25

30

35

2010 2011 2012 2013 2014 2015EPS Dividend

30

Dividend CAGR** +11% Dividend payout

EPS CAGR +2%

EPS* $

Dividend $

Cash return to shareholders

$m

Shareholder return

* Fully diluted basis, excl. restructuring and impairment. CAGR as reported. ** 2001-2014 period Dividend paid in Swiss Francs. Numbers include dividend and par value reduction Source: Company results

Documents

OUR PERFORMANCE - Syngenta...Long Term 2001-2015. BROAD CROP AND GEOGRAPHICAL FOOTPRINT . 9 . Sales in 90+ countries . Total: US$12.8bn . 8 key crops . North America . 3.4bn-4% CER